Medical triple net lease fund · Series 3 now open
Medical triple net lease fund · Series 3 now open
Invest in the real estate behind
essential healthcare.
We acquire, manage, and fund recession-resistant dental
and medical buildings on long-term triple-net leases.
Assets Under Management
$160M+
Buildings
102
States
27
Target Distribution
7-8%
Targets are not guaranteed and actual results may differ. Past performance does not predict future results. Offered under Regulation D 506(c) to accredited investors only.
Trusted by
Four ways to work with us
More than a fund. A platform
with four capabilities.
.01
Invest With Us
Access compelling, tax-advantaged medical real estate investments designed for accredited investors.
.02
Manage Your Property
Nationwide property management for dental, veterinary, and medical real estate.
.03
Grow Your Healthcare Business
Strategic advisory services, industry expertise, and connections for healthcare entrepreneurs.
Our portfolio
A track record and portfolio
Buildings
102
States
27
Assets Under Management
$160M+
- Annual NOI
$10.3M
Tenant credit tier framework
101 buildings and 115 tenants fully scored · as of October 2026
Tier 1- 74%
Tier 2- 7%
Tier 3- 19%
Tier 1
Parent revenue ≥$50M or named institutional PE sponsor
74% of NOI
73 buildings
Named institutional PE sponsors include Warburg Pincus, Linden Capital, Morgan Stanley Private Credit, Compass Group, Health Enterprise Partners, BlackRock, and Chicago Pacific Founders. Aggregate Tier 1 parent revenue exceeds $2.5 billion.
Tier 2
Parent revenue $25M–$50M, corporate financials on file
7% of NOI
7 buildings
Multi-site operators with corporate financials on file. Strong rent coverage ratios and corporate guarantees.
Tier 3
Practice-level financials only, parent revenue <$25M
19% of NOI
21 buildings
Practice-level financials only. Real estate fundamentals and sub-65% LTV are the primary credit anchor.
Tenant credit tier framework
114 tenants across 102 buildings · 3 healthcare categories
Dental
Incl. oral surgery, orthodontics, endodontics & pediatric dental
73% of NOI
64 Tenants
Specialty Medical
Plastic surgery, dermatology, orthopedic, urgent care & ancillary
18% of NOI
22 Tenants
Veterinary
Companion & specialty animal health
.
9% of NOI
10 Tenants
Predominantly PE-backed. Recession-resistant, non-discretionary demand.
Geographic footprint
84 buildings across 27 states · all four NAR regions
Midwest
41.3%
30 buildings · 19 owned · 11 pipeline
IL, IN, MI, MN, MO, OH, WI
South
29.7%
30 buildings · 19 owned · 11 pipeline
AL, AR, FL, KY, MS, OK, TN, TX, VA
Northeast
15.9%
14 buildings · 10 owned · 4 pipeline
CT, ME, NH, NJ, NY, PA
West
13.1%
10 buildings · 10 owned
AZ, CA, CO, UT, WA
Diversified across all four NAR regions with no single state above 13.0% of NOI — concentration risk stays low as the platform scales.
Our Offerings
7–8%
Average cash-on-cash
2.0x
Equity multiple
16–20%
Targeted IRR
25%–35%
Targeted IRR (upside)
5 Years
Holding Period
Targets are not guaranteed and actual results may differ. Past performance does not predict future results. Offered under Regulation D 506(c) to accredited investors only.
Find your Fit
Three Paths to Invest With Us
Targets are not guaranteed and actual results may differ. Past performance does not predict future results. Offered under Regulation D 506(c) to accredited investors only.
The Thesis
Triple-net medical vs. multifamily
Multifamily
Triple-net medicalOUR FOCUS
Who pays expenses
Landlord absorbs operating costs
Tenant pays taxes, insurance and maintenance (NNN)
Lease length
1 to 2 years standard
10 to 15 years standard
Tenant
Individual households
Healthcare operators, many PE-backed
Inflation protection
Mark-to-market at renewal
2 to 3% annual rent escalations built into the lease
Tenant turnover
Higher turnover is common
Low: costly specialized build-outs keep tenants in place
Management intensity
Heavy: many units, many tenants
Light: one tenant per building
Investor’s Stories
Hear from the people investing alongside us.
From healthcare professionals to experienced executives, our investors value a disciplined approach to medical real estate, transparent communication, and a long-term partnership.
“He understands an old real estate adage that you make your profits on the buy, not the sell.”
Dr Lou T
Owner Orthodontist
“A.J. made it an easy choice to invest. The value of my investment has increased and it has provided passive income.”
Dr Tont. L.
Owner Dentist
“Quick, easy, and simple. The returns have been met. I would do it all over again.”
Dr. Scott F.
Owner Dentist
“We get to reap the rewards of commercial real estate without all the hassle, in a hands-off, stress-free manner.”
Dan N.
DoD Program Manager
“A.J. has been a transparent, patient, and thorough managing partner, guiding all of us through both periods of aggressive growth and prudent retrenchment.”
Sam S.
CFO, Latitude Food Allergy Care
Testimonials reflect the individual experiences of current investors and may not be representative of other investors’ experiences.
Targets are not guaranteed and actual results may differ. Past performance does not predict future results. Offered under Regulation D 506(c) to accredited investors only.
See your projected returns.
An illustration at the fund's target range (Series 3). Not a forecast or a promise of returns.
$100K minimum$500K: Class A-2$2M
Class A-1$100K to $499K · 8% preferredClass A-2$500K and up · 9% preferred
12%Base case: 17% A-1 · 18% A-225%
2 yrs5 yrs
Year-one estimated paper loss
(cost segregation, ~60% of investment)
(cost segregation, ~60% of investment)
~$60,000
Projected total value at exitClass A-1
$164,303
Equity multiple1.64x
Annual distributions
at 7% target
at 7% target
$7,000
Total distributions
over the hold
over the hold
$21,000
Proceeds at exit
(capital + appreciation)
(capital + appreciation)
$143,303
Value by yearTotal profit $64,303
Cumulative distributionsCapital and appreciation
Class terms per the Series 3 PPM Supplement (Feb 2026). Targets are not guaranteed and actual results may differ. Past performance does not predict future results. Offered under Regulation D 506(c) to accredited investors only.